Microbubble driven multimodal imaging and theranostics for gliomas.
The idea of TheraGlio is to develop a multimodal imaging system for Theranostics (therapy+diagnosis) of patients bearing malignant glioma, the most common primary brain tumour.
This technology will avail of new generation Microbubbles (MBs) that can simultaneously act as drug delivery system and contrast agent for Magnetic Resonance Imaging, intra-operative Contrast-Enhanced Ultrasound and intra-operative fluorescence microscopic. This novel imaging system will provide multimodal image guidance during tumour resection with the final goal of prolonging patients' survival, as a result of a safer and larger tumour resection and tailored delivery of specific chemotherapeutic molecules.
Consortium: 11 partners from 5 countries
Coordinator of the project: Fondazione IRCCS Istituto Neurologico Carlo Besta – Italy
Funding programme: FP7-HEALTH
Project start: October 2013
End date for the project: 30 September 2018
For more information go to the website www.theraglio.eu